PMS5 COST-EFFECTIVENESS OF THE USE OF ETANERCEPT VS ANTI-TNF MONOCLONAL ANTIBODIES IN PATIENTS WITH RHEUMATOID ARTHRITIS IN MEXICO

Autor: Aguirre, A, García, E, Bierschwale, H, Arce, CA
Zdroj: In Value in Health 2009 12(7):A522-A523
Databáze: ScienceDirect